enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
9.83
+0.02 (0.20%)
At close: May 18, 2026, 4:00 PM EDT
9.75
-0.08 (-0.81%)
After-hours: May 18, 2026, 4:56 PM EDT
enVVeno Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
6.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 17.44M |
| Beyond Air | 6.92M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| Sintx Technologies | 1.02M |
| Co-Diagnostics | 718.17K |
| iTonic Holdings | 523.03K |
NVNO News
- 6 days ago - enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment - Accesswire
- 11 days ago - enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year - TheFly
- 11 days ago - enVVeno Medical sees cash runway into 3Q27 - TheFly
- 11 days ago - enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter - TheFly
- 11 days ago - enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System - Accesswire
- 19 days ago - enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study - TheFly
- 19 days ago - enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve - Accesswire
- 7 weeks ago - enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TheFly